NPCENeuroPace, Inc.
14.03USD-4.17%Mkt Cap: 481.57M $P/E:

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source …

Key Statistics

Company
Market Cap481.57M $
Enterprise Value499.46M $
Revenue (TTM)106.99M $
Gross Profit77.22M $
Net Income (TTM)-21.46M $
Revenue/Share3.185 USD
Last Price14.03 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees220
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-63.10
PEG
EV/EBITDA-42.05
EV/Revenue4.67
P/S4.50
P/B40.40
EPS (TTM)-0.45
EPS (Forward)-0.22
52W Range
8.17051% of range19.60
52W High19.60 USD
52W Low8.170 USD
Profitability
Gross Margin77.23%
Oper. Margin-22.53%
EBITDA Margin-11.10%
Profit Margin-21.47%
ROE-112.79%
ROA-20.33%
Growth
Revenue Growth17.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-11.01M $
CapEx (TTM)332.00K $
FCF Margin-2.46%
FCF Yield-0.55%
Net Debt18.23M $
Net Debt/EBITDA-1.54
Balance Sheet
Debt/Equity3.72
Current Ratio4.94
Quick Ratio3.82
Book Value/Sh0.3470 USD
Cash/Share1.506 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.22 USD
Upside (mean)+44.1%
Target Range18.00 USD22.00 USD
$18.00+44.1% to mean$22.00
# Analysts9
Ownership
Shares Out.34.32M
Float25.64M
Insiders4.01%
Institutions93.90%
Short Interest
Short Ratio4.5d
Short % Float2.78%
Short % Out.2.41%
Shares Short822.13K
Short (prev mo.)898.59K
Technical
SMA 5015.36 (-8.7%)
SMA 20015.36 (-8.7%)
Beta1.94
S&P 52W Chg18.16%
Avg Vol (30d)198.01K
Avg Vol (10d)177.45K
Technical Indicators
RSI (14)48.2
MACD-0.2683
MACD Signal-0.3728
MACD Hist.+0.1045
BB Upper15.68 USD
BB Middle14.39 USD
BB Lower13.10 USD
BB Width17.92%
ATR (14)0.8125 USD
Vol Ratio (20d)0.42x